Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Compass Therapeutics Inc’s stock clocked out at $2.47, up 23.50% from its previous closing price of $2.00. In other words, the price has increased by $23.50 from its previous closing price. On the day, 2.5 million shares were traded. CMPX stock price reached its highest trading level at $2.47 during the session, while it also had its lowest trading level at $2.02.
Ratios:
To gain a deeper understanding of CMPX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 31.84 and its Current Ratio is at 31.84. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on December 23, 2024, initiated with a Buy rating and assigned the stock a target price of $32.
On November 15, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $5 to $4.
Ladenburg Thalmann Upgraded its Neutral to Buy on September 16, 2024, while the target price for the stock was maintained at $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 339844800 and an Enterprise Value of 211320256. For the stock, the TTM Price-to-Sale (P/S) ratio is 399.82 while its Price-to-Book (P/B) ratio in mrq is 2.46. Its current Enterprise Value per Revenue stands at 248.612 whereas that against EBITDA is -3.854.
Stock Price History:
The Beta on a monthly basis for CMPX is 0.69, which has changed by 0.38888884 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $2.68, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 53.68%, while the 200-Day Moving Average is calculated to be 67.99%.
Shares Statistics:
It appears that CMPX traded 961.16K shares on average per day over the past three months and 3445660 shares per day over the past ten days. A total of 137.59M shares are outstanding, with a floating share count of 84.48M. Insiders hold about 38.60% of the company’s shares, while institutions hold 39.11% stake in the company. Shares short for CMPX as of 1735603200 were 2210789 with a Short Ratio of 2.30, compared to 1732838400 on 1451920. Therefore, it implies a Short% of Shares Outstanding of 2210789 and a Short% of Float of 2.27.
Earnings Estimates
The market rating for Compass Therapeutics Inc (CMPX) is a result of the insights provided by 7.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.27 and -$0.4 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.38, with 7.0 analysts recommending between -$0.19 and -$0.68.
